MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 55 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -23.1% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | +62.5% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -27.3% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $11,000 | -21.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,000 | +75.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | -88.6% | 10,000 | -88.9% | 0.00% | -83.3% |
| Q2 2020 | $70,000 | +29.6% | 90,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $54,000 | -52.6% | 90,000 | +80.0% | 0.01% | -50.0% |
| Q4 2019 | $114,000 | +256.2% | 50,000 | 0.0% | 0.01% | +200.0% |
| Q3 2019 | $32,000 | -25.6% | 50,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $43,000 | -21.8% | 50,000 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $55,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,923,000 | $509,990 | 0.12% |
| Arkadios Wealth Advisors | 1,399,000 | $181,870 | 0.02% |
| NEVILLE RODIE & SHAW INC | 1,157,332 | $150 | 0.01% |
| Platform Technology Partners | 162,410 | $21,113 | 0.01% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $101 | 0.01% |
| Main Street Financial Solutions, LLC | 400,826 | $52,107 | 0.01% |
| National Wealth Management Group, LLC | 42,750 | $5,558 | 0.01% |
| STALEY CAPITAL ADVISERS INC | 400,000 | $52,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 754,732 | $98,115 | 0.00% |
| HYMAN CHARLES D | 79,800 | $10,000 | 0.00% |